69 Biotech Startups in Germany to Watch in 2024
How do we build this list?
Last update to the database: May 26, 2024. See changelog.
Join 23,000+ founders, operators and investors.
Seedtable Score Learn how we calculate it here
We use raw data and human intuition to understand if a company is likely to outsource services like Hiring, Design, Development, etc.
company | score | funding | investors | employees | industries | biz model | city | contact |
---|---|---|---|---|---|---|---|---|
Developer of chemotherapeutic drugs designed to fight against cancer and chronic diseases. |
$139M · Series B | Nextech Invest, EQT Life Sciences, Andera Partners | 11 to 50 | Health Tech, Biotech, Deep Tech | B2B | Munich, Germany | •••••••••••@tubulis.com | |
Developer of next-generation T cells against solid tumors. |
$9M · Seed | Brandenburg Kapital, i&i Biotech Fund | 1 to 10 | Health Tech, Biotech | Berlin, Germany | •••••••••••@captaintcell.com | ||
Fat ingredient producer for alternative meats. |
$2M · Seed | b.value AG, Life Science Valley Wachstumsfond, Kale United | 1 to 10 | Foodtech, Biotech | B2B | Berlin, Germany | •••••••••••@cultimatefoods.com | |
Cloud-native chemical simulation platform. |
$3M · Seed | Chemovator, Ananda Impact Ventures, IBB Ventures | 11 to 50 | Biotech, Cloud | B2B, SaaS | Berlin, Germany | •••••••••••@quantistry.com | |
Innovative immunotherapies developer for cancer patients. |
$150M · Series D | Brandon Capital, Bioqube Ventures, Forbion Capital Partners | 11 to 50 | Health Tech, Biotech | B2B | Munich, Germany | •••••••••••@catalym.com | |
Manufacturer of sustainable biological binding of materials. |
$10M · Series B | HG Ventures, High-Tech Gründerfonds | 11 to 50 | Biotech, Deep Tech | B2B | Munich, Germany | •••••••••••@bind-x.com | |
Developer of bio-fabricated silk protein materials. |
$27M · Series C | Novo A/S | 11 to 50 | Health Tech, Biotech, Manufacturing | B2B | Munich, Germany | •••••••••••@amsilk.com | |
Diagnosis and treatment of hard-to-treat cancers. |
$24M · Series A | Earlybird Venture Capital, Andera Partners, HealthCap | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Berlin, Germany | •••••••••••@ariceum-therapeutics.com | |
Skin-identical collagen designed for premium personal care formulations. |
$8M · Seed | Essential Capital, SNR.vc, Valor Equity Partners | 11 to 50 | Health Tech, Biotech | Berlin, Germany | •••••••••••@cambrium.bio | ||
AI platform for radiology diagnostics. |
$5M · Seed | xdeck, 10x Founders | 11 to 50 | Health Tech, Biotech | Munich, Germany | •••••••••••@floy.com | ||
Biotech company that uses fermentation to create sustainable foods from mushroom roots. |
$10M · Series A | Redalpine | 1 to 10 | Foodtech, Biotech | B2C | Berlin, Germany | •••••••••••@mushlabs.com | |
Advanced bio-based ingredients manufacturer. |
$15M · Seed | EQT Ventures, Possible Ventures, Inventures SA | 11 to 50 | Biotech, Manufacturing | B2B | Munich, Germany | •••••••••••@insempra.bio | |
Platform that helps laboratory teams make groundbreaking discoveries and create high-quality products. |
$6M · Series B | IBB Ventures | 51 to 100 | Health Tech, Hardware, Biotech, Deep Tech, Enterprise Software | B2B, SaaS | Berlin, Germany | •••••••••••@labforward.io | |
Pioneer in precision medicine for psychiatry based in Munich. |
$10M | ALSTIN Capital | 11 to 50 | Health Tech, Biotech, Deep Tech, Pharma, Manufacturing | B2B | Munich, Germany | •••••••••••@hmnc-brainhealth.com | |
AI-powered radiology diagnostics platform. |
$1M · Pre Seed | Fund F, Bayern Kapital, Nina Capital | 1 to 10 | Health Tech, Biotech | B2B, SaaS | Munich, Germany | •••••••••••@ryver.ai | |
Cryotherapy system focused on development, clinical benefit demonstration, and commercialization. |
$10M · Series B | Meusinvest (Noshaq), Yellowstone Holding, Peppermint Venture Partners | 1 to 10 | Health Tech, Biotech, Manufacturing | B2B | Potsdam, Germany | •••••••••••@cryotherapeutics.com | |
Cancer cell-mapping technology. |
$21M · Seed | Sofinnova Partners, AbbVie Biotech Ventures, Panakes Partners | 11 to 50 | Biotech, Deep Tech | Cologne, Germany | •••••••••••@discopharma.de | ||
Gene editing therapeutics. |
$12M · Seed | Forbion Capital Partners, Wellington Partners | 51 to 100 | Biotech, Genetics | Dresden, Germany | •••••••••••@seamlesstx.com | ||
Drug discovery DAO. |
$3M · Seed | Inflection | 1001 to 5000 | Crypto & web3, Biotech | Berlin, Germany | •••••••••••@labdao.xyz | ||
Green chemical manufacturer. |
$2M · Seed | btov Partners, Octopus Ventures, Auxxo | 11 to 50 | Biotech, Manufacturing | B2B | Berlin, Germany | •••••••••••@dudechem.com | |
Lab-made cheese maker. |
$4M · Seed | Lowercarbon Capital, Agronomics, Elevat3 Capital | 11 to 50 | Foodtech, Biotech | B2C | Berlin, Germany | •••••••••••@formo.bio | |
Platform specializing in mid-infrared spectroscopy for bioprocessing and biotechnological solutions. |
$3M · Seed | High-Tech Gründerfonds, Verve Ventures | 11 to 50 | Health Tech, Biotech, Manufacturing, Future of Work | B2B | Munich, Germany | •••••••••••@irubis.com | |
LEVY is a Software-as-a-Medical Device (SaMD) for infertility diagnostics and individual therapeutic strategies. |
$2M · Pre Seed | Calm/Storm Ventures, Atlantic Labs | 11 to 50 | Health Tech, Biotech, Femtech, Mobile, Business Intelligence, Fertility | B2C, Freemium | Berlin, Germany | •••••••••••@levy.health | |
Teledermatology. |
$3M · Seed | High-Tech Gründerfonds | 11 to 50 | Health Tech, Biotech | Berlin, Germany | •••••••••••@nia-medtech.com | ||
Digital therapeutics solutions for oncology. |
$3M · Series A | Simpact Ventures | 11 to 50 | Health Tech, Biotech | Berlin, Germany | •••••••••••@prosoma.com | ||
Technology that turns agricultural industry plant leftovers into natural biomaterials. |
$38M · Series A | Blue Oceans Partners, High-Tech Gründerfonds, Planet A Ventures | 11 to 50 | Biotech, Manufacturing | B2B | Hamburg, Germany | •••••••••••@traceless.eu | |
Platform for discovering and developing medicines to treat and prevent heart disease. |
$76M | BioMedPartners, High-Tech Gründerfonds, Inkef Capital | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Hanover, Germany | •••••••••••@cardior.de | |
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need. |
$99M | High-Tech Gründerfonds, Hadean Ventures | 1 to 10 | Health Tech, Biotech, Pharma, Fitness, Manufacturing | B2B | Duisburg, Germany | •••••••••••@emergencetx.com | |
Platform for clinical validation and product surveillance of medical devices and pharmaceutical products. |
$1M · Pre Seed | Nauta Capital | 51 to 100 | Health Tech, Biotech, Pharma, Data and Analytics, Business Intelligence | B2B, SaaS | Munich, Germany | •••••••••••@climedo.de | |
Platform for pharmacies to sell medication online. |
$500k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, Biotech | B2C, Marketplace | Munich, Germany | •••••••••••@sanvivo.eu | |
Platform that creates whole-cut meats from fungi using clean ingredients and minimal processing. |
$239k · Pre Seed | Blue Impact Ventures, Food Labs | 1 to 10 | Foodtech, Biotech, Manufacturing | B2B | Berlin, Germany | •••••••••••@bosquefoods.com | |
Therapeutic company focused on creating a digital treatment for myopia. |
$1M · Seed | Novartis Venture Fund | 1 to 10 | Health Tech, Hardware, Biotech | B2B | Berlin, Germany | •••••••••••@dopavision.com | |
Next-gen antibiotics. |
$1M · Seed | High-Tech Gründerfonds | 1 to 10 | Health Tech, Biotech | Munich, Germany | •••••••••••@smartbax.de | ||
Protein-based drugs. |
$500k · Pre Seed | Y Combinator | 1 to 10 | Health Tech, Biotech | Munich, Germany | •••••••••••@invitris.com | ||
Medical AI company with a focus on critical care. |
$17M · Series A | Sana Kliniken | 1 to 10 | Health Tech, Fintech, AI, Biotech, Mobile, Payments | B2B, B2C, SaaS | Aachen, Germany | •••••••••••@clinomic.ai | |
Crafting the future of personal health. |
$26M | 51 to 100 | Health Tech, Hardware, Biotech, Data and Analytics | Munich, Germany | •••••••••••@temedica.com | |||
Platform for developing new mental health treatments for unmet medical needs. |
$45M | 101 to 250 | Health Tech, Biotech, Deep Tech, Data and Analytics | B2B | Munich, Germany | •••••••••••@atai.life | ||
Platform for scientists to gain new insights in spatial biology using Molecular Cartography. |
$24M · Series A | High-Tech Gründerfonds | Health Tech, Biotech, Data and Analytics, Business Intelligence | B2B, SaaS | Düsseldorf, Germany | •••••••••••@resolvebiosciences.com | ||
Cannabis-based medicines developer. |
$21M · Series B | 51 to 200 | Health Tech, Biotech | Frankfurt, Germany | •••••••••••@avextra.com | |||
Digital platform helping people with thyroid disease prevent long-term health complications. |
N/A | IBB Ventures | 1 to 10 | Health Tech, Biotech, Mobile | B2B, B2C, Freemium | Berlin, Germany | •••••••••••@boostthyroid.com | |
Platform for removing carbon dioxide from the ocean using energy-efficient methods. |
N/A | Atlantic Labs | Biotech, Deep Tech, Energy & Nuclear, Manufacturing | B2B | Berlin, Germany | •••••••••••@carbonatlantis.com | ||
Biotechnology firm leveraging AI to expedite molecule creation. |
N/A | Picus Capital | 1 to 10 | AI, Biotech, Pharma, Business Intelligence | B2B | Munich, Germany | •••••••••••@molab.ai | |
protein engineering, ML, drug development |
N/A | Entrepreneur First, Picus Capital | 1 to 10 | Health Tech, Biotech, Deep Tech, Machine Learning, Pharma | B2B | Berlin, Germany | •••••••••••@cinference.bio | |
AI-driven deciphering of genetic diseases |
N/A | Entrepreneur First, Frontline Ventures | 11 to 50 | Health Tech, AI, Biotech, Machine Learning, Business Intelligence | B2B, SaaS | Berlin, Germany | •••••••••••@nostos-genomics.com | |
Quantum MRI agents for assessing early patient response. |
$30M · Series A | 51 to 100 | Health Tech, Biotech | Stuttgart, Germany | •••••••••••@nvision-imaging.com | |||
mRNA therapeutics and LNP delivery. |
$5M · Series A | Bill & Melinda Gates Foundation | 101 to 250 | Health Tech, Biotech | B2B | Munich, Germany | •••••••••••@ethris.com | |
Bacterial profiling and microbiome analysis. |
$14M · Series A | 51 to 100 | Biotech | Munich, Germany | •••••••••••@mbiomics.com | |||
Product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of inflammatory diseases. |
$2M · Seed | 1 to 10 | Health Tech, Biotech | B2C | Munich, Germany | •••••••••••@aatec-medical.com | ||
Developer of new immuno-virotherapies focused on treating cancer. |
$13M · Series A | High-Tech Gründerfonds, Seventure Partners, Coparion | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Essen, Germany | •••••••••••@abalos-tx.com | |
Platform providing digital solutions for early detection and follow-up of memory problems. |
$10M | High-Tech Gründerfonds, bmp Ventures | 1 to 10 | Health Tech, Biotech, Business Intelligence | B2B, SaaS | Magdeburg, Germany | •••••••••••@neotiv.com | |
German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development. |
$10M · Series A | Andera Partners | 1 to 10 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Heidelberg, Germany | •••••••••••@exciva.com | |
Immune cell-based extracorporeal sepsis therapy developer. |
$4M · Series A | 11 to 50 | Health Tech, Biotech | Rostock, Germany | •••••••••••@artcline.de | |||
Biotechnology company that develops novel biological therapies. |
$73M | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Freiburg, Germany | •••••••••••@elevabiologics.com | ||
Life science tools company serving customers in drug discovery, toxicology, industrial biotech, and stem cell research. |
$3M · Seed | High-Tech Gründerfonds | 11 to 50 | Biotech, Manufacturing | B2B | Mannheim, Germany | •••••••••••@facellitate.com | |
Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases. |
$4M · Series B | Aescap Venture, EMBL Ventures | 11 to 50 | Biotech, Pharma | B2C | Dortmund, Germany | •••••••••••@affectis.com | |
A biotechnology company focused on developing products to address areas of major unmet need. |
$21M · Series B | 51 to 100 | Biotech, Deep Tech, Manufacturing | Hamburg, Germany | •••••••••••@topas-therapeutics.com | |||
Medical products company focused on innovation. |
$23M | 11 to 50 | Health Tech, Hardware, Biotech, Deep Tech | B2B | Heidelberg, Germany | •••••••••••@precisis.de | ||
Platform enabling rapid, plant-based, cell-free protein expression for research, development, and production. |
$13M · Series A | 11 to 50 | Biotech, Deep Tech, Pharma, Manufacturing | B2B | Düsseldorf, Germany | •••••••••••@leniobio.com | ||
Technology company specializing in developing and selling innovative liquid analysis solutions. |
$17M | 51 to 100 | Health Tech, Hardware, Biotech, Deep Tech, Manufacturing, Pet Tech | B2B | Dresden, Germany | •••••••••••@anvajo.com | ||
Face recognition for payments and financial services. |
N/A | 11 to 50 | AI, Biotech | Munich, Germany | •••••••••••@saffe.co | |||
Lignopure provides plant-based ingredients based on lignin for high value markets |
$2M · Seed | 11 to 50 | Biotech, Deep Tech | Hamburg, Germany | •••••••••••@lignopure.de | |||
Membrane technology that offers multifunctional and controllable separation techniques. |
N/A | High-Tech Gründerfonds | 11 to 50 | Health Tech, Biotech, Deep Tech, Manufacturing, Business Intelligence, Developer Tools | B2B | Dresden, Germany | •••••••••••@i3membrane.de | |
Diagnostics company specializing in identifying infections quickly. |
N/A | Earlybird Venture Capital, High-Tech Gründerfonds, Paua Ventures | 11 to 50 | Health Tech, Biotech, Pharma | B2B | Duisburg, Germany | •••••••••••@noscendo.com | |
Production of bacterial single cell protein solutions |
N/A | Astanor Ventures, Faber Ventures, Food Labs | 1 to 10 | Agritech, Foodtech, Biotech, Manufacturing | B2B | Hamburg, Germany | •••••••••••@microharvest.com | |
Virtual reality platform for innovative rehabilitation treatment. |
$1M | 1 to 10 | Health Tech, Hardware, AR / VR, Biotech | B2B | Heidelberg, Germany | •••••••••••@livingbrain.de | ||
Biotech firm focused on commercializing new technology. |
N/A | 11 to 50 | Biotech, Deep Tech | Cologne, Germany | •••••••••••@ayoxxa.com | |||
Therapeutics platform creating proteins and antibodies with human-like glycosylation. |
N/A | 11 to 50 | Health Tech, Biotech, Pharma, Manufacturing | B2B | Cologne, Germany | •••••••••••@cevec.com | ||
Drug discovery platform assisting pharmaceutical and biotechnology companies in finding new medicines. |
N/A | 1001 to 5000 | Biotech, Deep Tech | Hamburg, Germany | •••••••••••@evotec.com | |||
Biotechnology company specializing in producing peptides and proteins. |
N/A | 11 to 50 | Biotech, Deep Tech | Düsseldorf, Germany | •••••••••••@numaferm.com |
Sign up to access our full database
Enter your email and get access to 18,000+ technology companies you can partner with.